Olive Diagnostics

Company Overview

Snapshot

Founded in January 2019 by Guy Goldman, Olive Diagnostics is a Health Tech & Life Sciences company with 11–50 employees. The company has raised $11.75 million across 7 funding rounds from 8 investors. In March 2023, Mekorot invested in Olive Diagnostics to monitor Kinneret pollution.

Business overview

Olive Diagnostics develops a non-invasive passive urinalysis sensor that provides real-time health alerts, early detection, and information on disease progression. The sensor, mounted inside a toilet, uses optics to detect urine composition and sends data to the cloud. AI algorithms process this data to identify molecular characteristics and biomarkers, delivering findings to users via a mobile application or medical supervisors, and integrating biomarker data directly into electronic health record systems. The device monitors various biomarkers for hydration, pregnancy, ovulation, kidney stones, urinary tract infections, preeclampsia, diabetes, and changes in urination patterns, serving markets in North America, Europe, and Israel.

Strategic signal

In March 2023, Olive Diagnostics secured an investment from Mekorot, Israel's national water company, specifically for monitoring Kinneret pollution. This strategic investment signals a potential expansion of Olive Diagnostics' technology beyond human health diagnostics into environmental monitoring, showcasing the versatility and broader applicability of its urinalysis platform.

Company Intelligence Q&A

What is Olive Diagnostics' core technology?

Olive Diagnostics utilizes a non-invasive passive urinalysis sensor that employs optics for data collection. This sensor detects the composition of urine and sends the data to the cloud, where AI algorithms process it to identify molecular characteristics and biomarkers.

When did Olive Diagnostics exit stealth mode?

In September 2020, Olive Diagnostics exited stealth mode, unveiling its hands-free urinalysis solution designed for consumer use.

Which program did Olive Diagnostics join in March 2023?

In March 2023, Olive Diagnostics was selected to join the prestigious "Google for Startups Growth" program, indicating recognition of its potential and growth trajectory within the medtech sector.

What was a significant investment in Olive Diagnostics in March 2023?

In March 2023, Mekorot invested in Olive Diagnostics, with a specific focus on monitoring Kinneret pollution, highlighting a potential application of the company's technology beyond traditional healthcare.